Ownership

Louise Rodino-Klapac - Insider Trading & Ownership

Entity: Individual
Location: 215 First Street, Ste 415, Cambridge, MA
Summary: The estimated net worth of Louise Rodino-Klapac is at least $10.5M dollars as of March 11, 2025. Louise Rodino-Klapac is the Head of R&D, CSO of Sarepta Therapeutics, Inc. and owns shares of Sarepta Therapeutics, Inc. (SRPT) stock worth about $10.5M.
All Insider Reports: All Insider Reports

Ownership of Louise Rodino-Klapac

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
SRPT	Sarepta Therapeutics, Inc.	Head of R&D, CSO	$10.5M			Mar 7, 2025

Insider Transactions Reported by Louise Rodino-Klapac:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.